Mir A. Imran
CIK: 0001031686
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Rani Therapeutics Holdings, Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jul 21, 2026RANI
Rani Therapeutics Holdings, Inc.
Purchase(P)Direct36K shares at avg. $0.69$25K - May 28, 2026RANI
Rani Therapeutics Holdings, Inc.
Award(A)DirectDirector Stock Option (Right to Buy)
123.6K shares- - Oct 23, 2025RANI
Rani Therapeutics Holdings, Inc.
Purchase(P)Direct2.1M shares at avg. $0.60$1.3M - May 28, 2025RANI
Rani Therapeutics Holdings, Inc.
Award(A)DirectDirector Stock Option (Right to Buy)
50K shares- - Dec 16, 2024RANI
Rani Therapeutics Holdings, Inc.
Disposition(D)DirectStock Option (Right to Buy)
101.3K shares- - Dec 16, 2024RANI
Rani Therapeutics Holdings, Inc.
Award(A)DirectStock Option (Right to Buy)
101.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 21, 2026 | RANI Rani Therapeutics Holdings, Inc. | Purchase(P) | 36,000 | $0.69 | $24,840 | Direct |
| May 28, 2026 | RANI Rani Therapeutics Holdings, Inc. | Award(A) Director Stock Option (Right to Buy) | 123,600 | - | - | Direct |
| Oct 23, 2025 | RANI Rani Therapeutics Holdings, Inc. | Purchase(P) | 2,083,334 | $0.60 | $1,260,417 | Direct |
| May 28, 2025 | RANI Rani Therapeutics Holdings, Inc. | Award(A) Director Stock Option (Right to Buy) | 50,000 | - | - | Direct |
| Dec 16, 2024 | RANI Rani Therapeutics Holdings, Inc. | Disposition(D) Stock Option (Right to Buy) | 101,276 | - | - | Direct |
| Dec 16, 2024 | RANI Rani Therapeutics Holdings, Inc. | Award(A) Stock Option (Right to Buy) | 101,276 | - | - | Direct |
1-6 of 6 transactions
About IMRAN MIR A
IMRAN MIR A (SEC CIK 0001031686) files insider reports with the SEC as Director of Rani Therapeutics Holdings, Inc. (RANI).
Signal8 holds 5 ownership filings by IMRAN MIR A, all Form 4s, filed between Dec 17, 2024 and Jul 23, 2026. Those filings report 6 transactions, from Dec 16, 2024 to Jul 21, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on IMRAN MIR A's filings is in SAN JOSE, CA.
Recent filings by IMRAN MIR A
- Jul 21, 2026: Open-market purchase of RANI shares (Form 4, code P).
- May 28, 2026: Grant or award of RANI derivative securities (Form 4, code A).
- Oct 23, 2025: Open-market purchase of RANI shares (Form 4, code P).
- May 28, 2025: Grant or award of RANI derivative securities (Form 4, code A).
- Dec 16, 2024: Disposition to issuer transaction of RANI derivative securities (Form 4, code D).
Other insiders filing for Rani Therapeutics Holdings, Inc. (RANI)
- Imran Talat, Chief Executive Officer
- Javadi Alireza, Chief Technical Officer
- Gilson Michelle, Director
- Maestas Nicholas, Chief Financial Officer
- McKinley Kate, Chief Business Officer
- Bassan Abraham, Director